A randomized phase II study of PX-12, an inhibitor of thioredoxin in patients with advanced cancer of the pancreas following progression after a gemcitabine-containing combination. (Q50553669)
Jump to navigation
Jump to search
scientific article published on 12 May 2010
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A randomized phase II study of PX-12, an inhibitor of thioredoxin in patients with advanced cancer of the pancreas following progression after a gemcitabine-containing combination. |
scientific article published on 12 May 2010 |
Statements
1 reference
A randomized phase II study of PX-12, an inhibitor of thioredoxin in patients with advanced cancer of the pancreas following progression after a gemcitabine-containing combination. (English)
1 reference
Ramesh K Ramanathan
1 reference
James Abbruzzese
1 reference
Tomislav Dragovich
1 reference
Lynn Kirkpatrick
1 reference
Jose M Guillen
1 reference
Amanda F Baker
1 reference
Linda A Pestano
1 reference
Sylvan Green
1 reference
Daniel D Von Hoff
1 reference
12 May 2010
1 reference
67
1 reference
3
1 reference
503-509
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference